. Author manuscript; available in PMC: 2014 May 1.

Published in final edited form as: Neurol Clin. 2013 Feb 19;31(2):491–510. doi: 10.1016/j.ncl.2013.01.005

Table 6.

Guillain-Barre’ Syndrome: PE monotherapy, IVIg monotherapy, versus PE followed by IVIg (69)

	PE	IVIg	PE followed by IVIg
Total patients	121	130	128
Days to walk unaided	49	51	40
Median days to hospital discharge	63	53	51
% Unable to walk unaided after 48 weeks	16.7	16.5	13.7
Median days to stop artificial ventilation	29	26	18
Deaths	4.1%	4.6%	6.3%